Printer Friendly

Articles from Chain Drug Review (February 16, 2004)

1-84 out of 84 article(s)
Title Author Type Words
'Business as usual no longer an option'. 287
'Performance-driven industry' shows its Mettle. Industry Overview 559
Almay Clear Complexion fights, hides blemishes. Brief Article 163
Amgen profits advance 37%; sales up 58%. Brief Article 214
ArcLight strengthens analytical tools. Brief Article 276
Bad habits are hard to change. 528
Big guns promote e-scripts. Brief Article 215
BIO pitches its priorities in letter to Bush. 407
California regs draw fire from Walgreens. 442
Cardinal earnings up modestly in qtr. 1357
Chain drug retailing from a global perspective. Pinto, David 731
Chain drug stocks off as new year begins. 1133
Chain fliers pull in the shoppers. 300
Chain marketing tells the story: it's now a digital world. 1343
CHPA outlines goals for '04. 694
Consumer group sues maker of OxyContin. 504
Cost of Medicare drug benefit soars. Brief Article 291
CVS emerges as a pioneer in photo. Brief Article 239
CVS finds 'suggestive selling' is the way to go. Brief Article 233
Drug chains have knack for in-store marketing. Vogel, Mike 762
Drug importation remains a very contentious issue. 574
Drugstore.com reaches milestone. 921
Eckerd touts its worth with promo that dares. 327
Editorial calendar '04. Calendar 460
Effort under way to hone Rx-to-O-T-C switch process. 523
Ephedra makes exit; what's coming next? 532
FDA and SEC to increase cooperation. Brief Article 226
FDA first-time generics approvals--2003. Illustration 1489
FDA works to protect consumer health. Brief Article 215
FDA: generics a better bet than imports. 498
Feldbaum to leave BIO at end of year. Brief Article 237
Fotiades appointed Cardinal president. Brief Article 176
Four suppliers win approvals from the FDA. Brief Article 200
Genentech awaits okay for potential blockbuster. Brief Article 251
Generics firms challenging Zyprexa patent. 327
GPhA meeting to probe challenges, opportunities. Brief Article 270
GSK will back NBC Health, Fitness Expos. Brief Article 210
Happy Harry's rejects mandatory mail plans. Brief Article 213
Health Care Logistics has solution. Brief Article 171
Herbals to get closer look from FDA. 317
Hy-Vee takes steps to combat methamphetamine production. 564
India becomes growing force in the industry. Brief Article 203
Informed consumers are the best Rx customers. 422
Internet pharmacies confront growing opposition in Canada. 374
IRS ruling to spur growth in FSAs for health care. 507
Katz Group strengthens exec ranks. 440
Klein to guide transformation of IRI. Brief Article 351
L'Oreal names Fondu Maybelline president. Brief Article 194
Lessons of generic conversion programs. 353
Maine Medicaid cuts spur Rite Aid to reduce hours. Brief Article 261
McClellan eyes challenges. 538
Merck gears up for new cholesterol drug. Brief Article 230
Merck's board of directors could face annual election. Brief Article 152
Michigan bills asks that Rx consumers have a choice. 443
More consumers need more scar management. 672
Myriad factors call for flexibility at retail. 410
NCPA posts go to Deck and Kneeland. Brief Article 218
New European union rules a blow to generics manufacturers. 411
New suppliers make an impact. 472
Nothing but blue skies. Monks, Richard 815
P&G receives license for Wella hair care lines. Brief Article 154
Penney's plans to divest Eckerd are still on track. 429
Pharmacists on front lines. 578
Pharmacy automation a growth category. Brief Article 211
Pharmacy Care Alliance seeks CMS endorsement. Brief Article 215
Relative newcomer packs big wallop. Paikert, Charles 616
Retail gets ready for change. Walden, Geoff 918
Retailers find consumers are willing to trade up. Paikert, Charles 736
Retailers promote generic drugs as a win-win-win proposition. 878
Revlon credit agreement amended. 245
Russ Berrie to add Mr. Meow plush toy to offerings. Brief Article 163
Rx moves to 'help control its destiny'. Walden, Geoff 602
Single-use cameras have room to grow. 474
Stormy December hurts results at Duane Reade. Brief Article 259
Study monitors trends in consumer e-health. 373
Study: echinacea is ineffective. Brief Article 108
The economic power of generic drugs. Coopman, Robert 604
The next big deficiency ... Brief Article 186
The next test of retail pharmacy's resolve. Woldt, Jeffrey 750
The state of the generic drug industry. Schultz, John 1000
Trojan's Warm Sensations. Brief Article 154
Vitamins in spray form launched. 328
What's new, traditional--both do well. 350
Wisconsin alters course on drug savings Web site. 317

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |